Plain-English translation of NCT07104240 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a comprehensive support package called TweenVax can help more young teens get the HPV vaccine. The HPV vaccine prevents certain cancers later in life. Researchers are giving some pediatric practices training, tools, and resources to help parents and teens understand why this vaccine matters, while other practices continue offering standard care.
Many young teens don't receive the HPV vaccine even though it's safe and prevents serious cancers. This trial is testing whether providing pediatricians and parents with better information, training, and resources can help more families choose vaccination.
You likely qualify if…
You likely don't qualify if…
If you enroll, you and your parent or guardian will visit your pediatrician's office during regular care. Depending on which group your practice is in, you may use a tablet to learn about the HPV vaccine, talk with your provider about why it's important, and discuss any questions or concerns with your parent. After the study intervention, your practice will be monitored for up to one year to track vaccination rates.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI)
Enrollment target
~1,836 participants
Started
May 2025
Primary completion
March 2027
Age range
9 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Robert Bednarczyk, PhD
Emory University Hospital/Winship Cancer Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.